CA1267899A - Compounds for site-enhanced delivery of radionuclides and uses thereof - Google Patents

Compounds for site-enhanced delivery of radionuclides and uses thereof

Info

Publication number
CA1267899A
CA1267899A CA000487165A CA487165A CA1267899A CA 1267899 A CA1267899 A CA 1267899A CA 000487165 A CA000487165 A CA 000487165A CA 487165 A CA487165 A CA 487165A CA 1267899 A CA1267899 A CA 1267899A
Authority
CA
Canada
Prior art keywords
salt
formula
alkyl
group
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000487165A
Other languages
English (en)
French (fr)
Inventor
Nicholas S. Bodor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Application granted granted Critical
Publication of CA1267899A publication Critical patent/CA1267899A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
CA000487165A 1984-07-19 1985-07-19 Compounds for site-enhanced delivery of radionuclides and uses thereof Expired - Fee Related CA1267899A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63231484A 1984-07-19 1984-07-19
US632,314 1984-07-19

Publications (1)

Publication Number Publication Date
CA1267899A true CA1267899A (en) 1990-04-17

Family

ID=24535023

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000487165A Expired - Fee Related CA1267899A (en) 1984-07-19 1985-07-19 Compounds for site-enhanced delivery of radionuclides and uses thereof

Country Status (13)

Country Link
EP (1) EP0187832A1 (de)
JP (1) JPS61106556A (de)
KR (1) KR900007514B1 (de)
AU (1) AU4635885A (de)
CA (1) CA1267899A (de)
DK (1) DK124786A (de)
ES (1) ES8704900A1 (de)
FI (1) FI861118A0 (de)
GR (1) GR851792B (de)
NO (1) NO860981L (de)
PT (1) PT80841B (de)
WO (1) WO1986000898A1 (de)
ZA (1) ZA855476B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888427A (en) * 1987-04-07 1989-12-19 University Of Florida Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain
US5079366A (en) * 1987-04-07 1992-01-07 University Of Florida Quarternary pyridinium salts
EP0301751B1 (de) * 1987-07-31 1993-03-10 Takeda Chemical Industries, Ltd. Pyridinium-Derivate, ihre Herstellung und Verwendung
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
JP4677863B2 (ja) * 2005-09-05 2011-04-27 堺化学工業株式会社 チオール系光硬化性モノマーおよび光硬化型樹脂組成物
US8701166B2 (en) 2011-12-09 2014-04-15 Blackberry Limited Secure authentication
US10864279B2 (en) 2016-12-16 2020-12-15 Industrial Technology Research Institute Linker-drug and antibody-drug conjugate (ADC) employing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224283A3 (de) * 1982-05-18 1988-09-21 University Of Florida Gehirnspezifische Arzneimittelabgabe

Also Published As

Publication number Publication date
ES552072A0 (es) 1987-04-16
PT80841B (en) 1987-06-03
EP0187832A1 (de) 1986-07-23
DK124786D0 (da) 1986-03-18
GR851792B (de) 1985-11-26
NO860981L (no) 1986-05-20
ES8704900A1 (es) 1987-04-16
WO1986000898A1 (en) 1986-02-13
AU4635885A (en) 1986-02-25
KR900007514B1 (ko) 1990-10-11
FI861118A (fi) 1986-03-18
DK124786A (da) 1986-05-20
FI861118A0 (fi) 1986-03-18
JPS61106556A (ja) 1986-05-24
KR860000871A (ko) 1986-02-20
PT80841A (en) 1985-08-01
ZA855476B (en) 1987-03-25

Similar Documents

Publication Publication Date Title
US5256676A (en) 3-hydroxy-pyridin-4-ones useful for treating parasitic infections
JPH0672097B2 (ja) 医薬用組成物
SU1402260A3 (ru) Способ получени @ S @ - @ -этил-2-оксо-1-пирролидинацетамида
JP3207901B2 (ja) レトロウイルス阻害性化合物
US5624901A (en) 3-hydroxy-2(1H)-pyridinone chelating agents
US5580904A (en) Formamido and carboxyamido compounds which can be retained in brain
US4963688A (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
DE4033415A1 (de) Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
EP0499501B1 (de) Neue makrocyclische Stickstoff-Liganden, Verfahren zu ihrer Herstellung, Metallkomplexe, diagnostische und therapeutische Zusammensetzungen
DE3332633A1 (de) Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
CA1267899A (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
KR960015002B1 (ko) 광학 활성 8-메톡시 퀴놀론카복실산 유도체, 이의 제조방법 및 이의 중간체
WO1995001346A1 (en) Chelating compounds
DE4345266A1 (de) Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
HU207293B (en) Process for producing compounds for marking proteines
WO1992017454A1 (en) Bis-naphthalimides containing amide and thioamide linkers as anticancer agents
IE871872L (en) Thiazolidine-4-carboxylic acid derivatives
CA2181308A1 (en) Improving the tolerability of pharmaceutically active beta-amino acids
CA1064932A (en) N-(4'-benzamido)-2-pyrrolidone-4-carboxylic acid compounds
US4304771A (en) Antihypertensive amides
CA1266864A (en) Radiopharmaceuticals and chelating agents useful in their preparation
US4507312A (en) Antihypertensive amides
DE2450161B2 (de) N-beta-(3',4'-dihydroxyphenaethyl)- glutamin und dessen alkylester sowie deren pharmakologisch vertraegliche saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
US5155227A (en) Compounds for site-enhanced delivery of radionuclides
JP2585079B2 (ja) 新規ジペプチド化合物

Legal Events

Date Code Title Description
MKLA Lapsed